Effects of smoking habit on the prevalence of Atrial fibrillation in Japanese patients with special reference to sex differences - Evidence from the Shinken database

Circulation Journal

Volumn 77, Issue 12, 2013, Pages 2948-2953

  Suzuki, Shinya ^a   Sagara, Koichi ^a   Otsuka, Takayuki ^a   Kano, Hiroto ^a   Matsuno, Shunsuke ^a   Takai, Hideaki ^a   Uejima, Tokuhisa ^a   Oikawa, Yuji ^a   Koike, Akira ^a   Nagashima, Kazuyuki ^a   Kirigaya, Hajime ^a   Yajima, Junji ^a   Tanabe, Hiroaki ^a   Sawada, Hitoshi ^a   Aizawa, Tadanori ^a   Yamashita, Takeshi ^a  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

Author keywords

Atrial fibrillation; Epidemiology; Risk factors; Smoking; Tobacco consumption

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; TOBACCO; VALVULAR HEART DISEASE;

AGED; ATRIAL FIBRILLATION; DATABASES, GENETIC; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; SEX CHARACTERISTICS; SMOKING;

EID: 84888265647     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0446     Document Type: Article

References (63)

1. Wolf PA, Mitchell JB, Baker CS, Kannel WB, Agostino RBD. Impact of atrial fbrillation on mortality, stroke, and medical costs. Arch Intern Med 1998; 158: 229-234.
2. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf Pa, et al. Temporal relations of atrial fbrillation and congestive heart failure and their joint infuence on mortality: The Framingham Heart Study. Circulation 2003; 107: 2920-2925.
3. Okumura K, Komatsu T, Yamashita T, Okuyama Y, Harada M, Konta Y, et al. Time in the therapeutic range during warfarin therapy in Japanese Patients with non-valvular atrial fbrillation. Circ J 2011; 75: 2087-2094.
4. Ogawa S, Koretsune Y, Yasaka M, Aizawa Y, Atarashi H, Inoue H, et al. Antithrombotic therapy in atrial fbrillation: Evaluation and positioning of new oral anticoagulant agents. Circ J 2011; 75: 1539-1547.
5. Atarashi H, Inoue H, Okumura K, Yamashita T, Kumagai N, Origasa H. Present status of anticoagulation treatment in Japanese patients with atrial fbrillation. Circ J 2011; 75: 1328-1333.
6. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fbrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagu-lation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
7. Ohsawa M, Okayama A, Sakata K, Kato K, Itai K, Onoda T, et al. Rapid increase in estimated number of persons with atrial fbrillation in Japan: An analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000. J Epidemiol 2005; 15: 194-196.
8. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, et al. Prevalence of atrial fbrillation in the general population of Japan: An analysis based on periodic health examination. Int J Cardiol 2009; 137: 102-107.
9. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fbrillation in a population-based cohort: The Framingham Heart Study. JAMA 1994; 271: 840-844.
10. Wang TJ, Parise H, Levy D, D'Agostino RB, Wolf Pa, Vasan RS, et al. Obesity and the risk of new-onset atrial fbrillation. JAMA 2004; 292: 2471-2477.
11. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, et al. Metabolic syndrome and risk of development of atrial fbrilla-tion: The Niigata preventive medicine study. Circulation 2008; 117: 1255-1260.
12. Iguchi Y, Kimura K, Kobayashi K, Aoki J, Terasawa Y, Sakai K, et al. Relation of atrial fbrillation to glomerular fltration rate. Am J Cardiol 2008; 102: 1056-1059.
13. Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y. Close bidirectional relationship between chronic kidney disease and atrial fbrillation: The Niigata preventive medicine study. Am Heart J 2009; 158: 629-636.
14. Alonso A, Lopez FL, Matsushita K, Loehr LR, Agarwal SK, Chen LY, et al. Chronic kidney disease is associated with the incidence of atrial fbrillation: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011; 123: 2946-2953.
15. Horio T, Iwashima Y, Kamide K, Tokudome T, Yoshihara F, Nakamura S, et al. Chronic kidney disease as an independent risk factor for new-onset atrial fbrillation in hypertensive patients. J Hypertens 2010; 28: 1738-1744.
16. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profles. Am Heart J 1991; 121: 293-298.
17. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
18. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profle for use in primary care: The Framingham Heart Study. Circulation 2008; 117: 743-753.
19. Group. NDR. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J 2006; 70: 1249-1255.
20. Epstein FH. The epidemiology of coronary heart disease: A review. J Chronic Dis 1965; 18: 735-774.
21. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 2004; 43: 1731-1737.
22. Read RC. Presidential address: Systemic effects of smoking. Am J Surg 1984; 148: 706-711.
23. Wilhelmsen L. Coronary heart disease: Epidemiology of smoking and intervention studies of smoking. Am Heart J 1988; 115: 242-249.
24. Benowitz NL. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med 1988; 319: 1318-1330.
25. Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA 1998; 279: 119-124.
26. Mehta M, Jain A, Mehta A, Billie M. Cardiac arrhythmias following intravenous nicotine: Experimental study in dogs. J Cardiovasc Pharmacol Ther 1997; 2: 291-298.
27. Stewart PM, Catterall JR. Chronic nicotine ingestion and atrial fbril-lation. Br Heart J 1985; 54: 222-223.
28. Nunes JP, Barbosa E, Lopes L, Alves C, Gonçalves FR. Nicotine nasal inhalation, atrial fbrillation and seizures. Cardiology 2001; 96: 58.
29. Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D'Agostino RB, et al. Development of a risk score for atrial fbrilla-tion (Framingham Heart Study): A community-based cohort study. Lancet 2009; 373: 739-745.
30. Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fbrillation or futter: The Danish Diet, Cancer, and Health Study. Am J Med 2005; 118: 489-495.
31. Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial f-brillation in the general male population: Morbidity and risk factors. J Intern Med 2001; 250: 382-389.
32. Krahn AD, Manfreda J-e, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fbrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995; 98: 476-484.
33. Ariansen I, Reims HM, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, et al. Impact of alcohol habits and smoking on the risk of new-onset atrial fbrillation in hypertensive patients with ECG left ventricular hypertrophy: The LIFE study. Blood Press 2012; 21: 6-11.
34. Heeringa J, Kors JA, Hofman A, van Rooij FJA, Witteman JCM. Cigarette smoking and risk of atrial fbrillation: The Rotterdam Study. Am Heart J 2008; 156: 1163-1169.
35. Chamberlain AM, Agarwal SK, Folsom AR, Duval S, Soliman EZ, Ambrose M, et al. Smoking and incidence of atrial fbrillation: Results from the Atherosclerosis Risk in Communities (ARIC) study. Heart Rhythm 2011; 8: 1160-1166.
36. Suzuki S, Yamashita T, Otsuka T, Sagara K, Uejima T, Oikawa Y, et al. Recent mortality of Japanese patients with atrial fbrillation in an urban city of Tokyo. J Cardiol 2011; 58: 116-123.
37. Suzuki S, Yamashita T, Ohtsuka T, Sagara K, Uejima T, Oikawa Y, et al. Prevalence and prognosis of patients with atrial fbrillation in Japan: A prospective cohort of Shinken Database 2004. Circ J 2008; 72: 914-920.
38. Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Uejima T, et al. A new scoring system for evaluating the risk of heart failure events in Japanese patients with atrial fbrillation. Am J Cardiol 2012; 110: 678-682.
39. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
40. Lawes CMM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, et al. Blood pressure and cardiovascular disease in the Asia Pacifc region. J Hypertens 2003; 21: 707-716.
41. Ueshima H. Explanation for the Japanese paradox: Prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb 2007; 14: 278-286.
42. Pandey MR. Tobacco smoking and hypertension. J Indian Med Assoc 1999; 97: 367-369.
43. Virdis A, Giannarelli C, Neves MF, Taddei S, Ghiadoni L. Cigarette smoking and hypertension. Curr Pharm Des 2010; 16: 2518-2525.
44. Halimi J-M, Giraudeau B, Vol S, Cacès E, Nivet H, Tichet J. The risk of hypertension in men: Direct and indirect effects of chronic smoking. J Hypertens 2002; 20: 187-193.
45. Watson L, Vonk JM, Löfdahl CG, Pride NB, Pauwels RA, Laitinen LA, et al. Predictors of lung function and its decline in mild to moderate COPD in association with gender: Results from the Euroscop study. Respir Med 2006; 100: 746-753.
46. Hurd S. The impact of COPD on lung health worldwide: Epidemiology and incidence. Chest 2000; 117: 1S-4S.
47. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18.
48. Halimi JM, Giraudeau B, Vol S, Cacès E, Nivet H, Lebranchu Y, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 2000; 58: 1285-1292.
49. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000; 133: 585-591.
50. Yoon H-J, Park M, Yoon H, Son K-Y, Cho B, Kim S. The differential effect of cigarette smoking on glomerular fltration rate and proteinuria in an apparently healthy population. Hypertens Res 2009; 32: 214-219.
51. Ishizaka N, Ishizaka Y, Toda E-i, Shimomura H, Koike K, Seki G, et al. Association between cigarette smoking and chronic kidney disease in Japanese men. Hypertens Res 2008; 31: 485-492.
52. Maeda I, Hayashi T, Sato KK, Koh H, Harita N, Nakamura Y, et al. Cigarette smoking and the association with glomerular hyperfltration and proteinuria in healthy middle-aged men. Clin J Am Soc Nephrol 2011; 6: 2462-2469.
53. Shibata Y, Watanabe T, Osaka D, Abe S, Inoue S, Tokairin Y, et al. Impairment of pulmonary function is an independent risk factor for atrial fbrillation: The Takahata study. Int J Med Sci 2011; 8: 514-522.
54. Buch P, Friberg J, Scharling H, Lange P, Prescott E. Reduced lung function and risk of atrial fbrillation in the Copenhagen City Heart Study. Eur Respir J 2003; 21: 1012-1016.
55. Jahangir A, Murarka S. Progression of paroxysmal to persistent atrial fbrillation factors promoting the HATCH score. J Am Coll Cardiol 2010; 55: 732-734.
56. Gu J, Liu X, Tan H, Zhou L, Jiang W, Wang Y, et al. Impact of chronic obstructive pulmonary disease on procedural outcomes and quality of life in patients with atrial fbrillation undergoing catheter ablation. J Cardiovasc Electrophysiol 2013; 24: 148-154.
57. Benowitz NL, Jacob P, Jones RT, Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 1982; 221: 368-372.
58. Haass M, Kübler W. Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther 1997; 10: 657-665.
59. Wang H, Shi H, Zhang L, Pourrier M, Yang B, Nattel S, et al. Nicotine is a potent blocker of the cardiac A-type K(+) channels: Effects on cloned Kv4.3 channels and native transient outward current. Circulation 2000; 102: 1165-1171.
60. Goette A, Lendeckel U, Kuchenbecker A, Bukowska A, Peters B, Klein HU, et al. Cigarette smoking induces atrial fbrosis in humans via nicotine. Heart 2007; 93: 1056-1063.
61. Goette A. Nicotine, atrial fbrosis, and atrial fbrillation: Do microRNAs help to clear the smoke? Cardiovasc Res 2009; 83: 421-422.
62. Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai B, et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009; 83: 465-472.
63. Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, et al. Asymptomatic atrial fbrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005; 149: 657-663.